Series D · Medtech & Devices · Cambridge, United Kingdom · Founded 2014 · 600–800 employees
CMR Surgical develops Versius, a next-generation modular surgical robot that makes minimally invasive surgery more accessible and affordable. The company has achieved unicorn status with a $3 billion valuation and has raised over $1.4 billion in total funding, including a record-breaking $600 million Series D in 2021. Versius has been used in over 30,000 surgical procedures across 30+ countries and is considered the second most-adopted soft tissue surgical robot globally. The company aims to democratize robotic surgery by providing a more flexible, portable, and cost-effective alternative to existing systems like Intuitive Surgical's da Vinci.